Epioxa
Payments companies reported to CMS as associated with Epioxa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Epioxa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Epioxa
These are the largest totals companies reported as associated with Epioxa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kenneth Beckman | Westerville, OH | Ophthalmology | $15,849.62 |
| Sila Bal | Honolulu, HI | Cornea and External Diseases Specialist | $13,650.00 |
| Natalie Afshari | La Jolla, CA | Ophthalmology | $13,596.00 |
| Duna Raoof | Laguna Hills, CA | Ophthalmology | $12,016.00 |
| John Berdahl | Sioux Falls, SD | Ophthalmology | $11,257.48 |
| Vance Thompson | Sioux Falls, SD | Ophthalmology | $9,748.26 |
| Neel Desai | Largo, FL | Ophthalmology | $9,718.62 |
| William Dupps | Cleveland, OH | Ophthalmology | $9,651.00 |
| Shahzad Mian | Ann Arbor, MI | Ophthalmology | $9,514.00 |
| Michael Straiko | Portland, OR | Cornea and External Diseases Specialist | $9,263.92 |
Prescribed Epioxa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.